Company Profile
Genext is a biotechnology company dedicated to developing special nano-drug delivery platforms. Aim to improve the properties of drugs and achieve even seemingly impossible effects in medical treatments. For example, liposomal products can enhance the pharmacokinetic characteristics of drugs, prolonging half-life and reducing toxicity by several orders of magnitude. Nucleic acid drugs, which have received significant attention in recent years, rely on Lipid NanoParticles drug delivery vehicles to enter human cells safely and achieve therapeutic benefits. Additionally, gold nanoparticles can also serve as a radiation sensitizer and utilize radiation to eliminate cancer cells within tumors, thereby enhancing the therapeutic effect.
Complete value chain
The development of these specialized nano-drug delivery systems requires a dense and complex value chain. It involves developing and producing special excipients, analyzing nanomedicines, screening nanomedicine formulations, cultivating animal test models, planning and supervising clinical trials, as well as designing and operating commercial GMP production plants. The Genext team has established an integrated value chain to meet the current demands and complexities of drug development.
Commercial mass production
Genext has extensive experience in the commercial mass production of these special nano-drug delivery drugs. Several team members have led and participated in constructing numerous commercial GMP factories and supplying products worldwide. This expertise enables Genext to smoothly launch and bring the benefits of nanomedicines to patients.